Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/277
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms
Description: Subject matter which contains a six-membered heterocyclic ring consisting of one nitrogen and five carbon atoms.

Sub-classes under this class:

Class Number	Class Name	Patents
514/336	Additional hetero ring containing	849
514/354	C=o bonded directly to the six-membered hetero ring	436
514/345	Chalcogen bonded directly to ring carbon of the six-membered hetero ring	721
514/344	Cyano bonded directly to the six-membered hetero ring	249
514/352	Nitrogen attached directly to the six-membered hetero ring by nonionic bonding	779
514/357	Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding	1,297
514/315	Piperidines	784
514/332	Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms	545
514/279	Polycyclo ring system having the six-membered hetero ring as one of the cyclos	278
514/278	Spiro ring system	797
514/358	The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)	152

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Patent Number	Title Of Patent	Date Issued
6649658	(-)-Verbenone derivatives	Nov. 18, 2003
6649623	Cyclic amine derivatives and use thereof	Nov. 18, 2003
6649616	Substituted phenylcyclohexanecarboxamides and their use	Nov. 18, 2003
6642273	Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics	Nov. 4, 2003
6638964	Sulfonamide-containing indole compounds	Oct. 28, 2003
6638941	Conformationallly constrained peptidomimetics as .beta.-turn templates and modulators of SH3 domains	Oct. 28, 2003
6638940	Tetrahydropyridines as pesticides	Oct. 28, 2003
6624173	Pharmaceutical compositions for treating and/or preventing CNS disorders	Sep. 23, 2003
6623724	Dermatological compositions and methods	Sep. 23, 2003
6613313	Aniline compound-containing hair dye composition and method of dyeing hair	Sep. 2, 2003
6608061	Bisaryl compound and medicament for cancer treatment comprising the same	Aug. 19, 2003
6608073	Intranasal codeine for the rapid suppression of cough and rapid relief of pain	Aug. 19, 2003
6608074	Contraception method using competitive progesterone antagonists and novel compounds useful therein	Aug. 19, 2003
6605612	Cardioprotective phosohonates and malonates	Aug. 12, 2003
6602896	p38MAPK inhibitor and uses thereof	Aug. 5, 2003
6602879	Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases	Aug. 5, 2003
6589997	Small-molecule modulators of hepatocyte growth factor/scatter factor activities	Jul. 8, 2003
6583158	Method for enhancing mutant enzyme activities in lysosomal storage disorders	Jun. 24, 2003
6579881	Indoles	Jun. 17, 2003
6573271	Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists	Jun. 3, 2003
6566381	Hetero-substituted metalloprotease inhibitors	May. 20, 2003
6566396	Antitussive/antihistaminic compositions	May. 20, 2003
6562824	Dihydropyridine soft drugs, and related compositions and methods	May. 13, 2003
6559157	Dihydronaphthalene compounds	May. 6, 2003
6551604	Skin care compositions	Apr. 22, 2003
6548514	Amide derivatives	Apr. 15, 2003
6548504	Compounds	Apr. 15, 2003
6545009	Retinoid-related receptor function regulating agent	Apr. 8, 2003
6541475	.alpha., .beta.-unsaturated sulfones for treating proliferative disorders	Apr. 1, 2003
6538029	Methods for treatment of renal cell carcinoma	Mar. 25, 2003
6534513	Phenylalkanoic acid derivatives	Mar. 18, 2003
6531480	Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders	Mar. 11, 2003
6528516	Methods for reducing intraocular pressure using A3 adenosine receptor antagonists	Mar. 4, 2003
6524556	Aerosol compositions	Feb. 25, 2003
6525065	Pharmaceutical compositions and methods for effecting dopamine release	Feb. 25, 2003
6521633	Treating NIDDM with RXR agonists	Feb. 18, 2003
6521609	Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes	Feb. 18, 2003
6514963	Methods for the inhibition of egg production in trematodes	Feb. 4, 2003
6514996	Derivatives of benzofuran or benzodioxole	Feb. 4, 2003
6515000	Fungicidal mixtures based on amide compounds	Feb. 4, 2003
6511985	Combination of cerivastatin and fibrates	Jan. 28, 2003
6509354	3-arylphenyl sulfide derivative and insecticide and miticide	Jan. 21, 2003
6506800	1,4 diaryl-2,3-difluoro-2-butene insecticidal and acaricidal agents	Jan. 14, 2003
6503917	2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof	Jan. 7, 2003
6503918	D-mannitol and its preparation	Jan. 7, 2003
6500832	.alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors	Dec. 31, 2002
6500849	1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino 1,3-propanediols and related compounds	Dec. 31, 2002
6498150	Low molecular weight cell, bone marrow and immune stimulants	Dec. 24, 2002
6492365	Microsomal triglyceride transfer protein	Dec. 10, 2002
6489334	Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms	Dec. 3, 2002